Virve I. Enne

2.8k total citations
37 papers, 1.8k citations indexed

About

Virve I. Enne is a scholar working on Molecular Medicine, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Virve I. Enne has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Medicine, 18 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Virve I. Enne's work include Antibiotic Resistance in Bacteria (22 papers), Pneumonia and Respiratory Infections (12 papers) and Antibiotic Use and Resistance (7 papers). Virve I. Enne is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Pneumonia and Respiratory Infections (12 papers) and Antibiotic Use and Resistance (7 papers). Virve I. Enne collaborates with scholars based in United Kingdom, United States and Sri Lanka. Virve I. Enne's co-authors include David M. Livermore, Lucinda M. C. Hall, Peter Stephens, J.M. Roe, Anne A. Delsol, Ronald N. Jones, Alan H. Mutnick, Vanya Gant, Peter M. Bennett and Alimuddin Zumla and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Clinical Microbiology.

In The Last Decade

Virve I. Enne

37 papers receiving 1.8k citations

Peers

Virve I. Enne
Eun-Jeong Yoon South Korea
Margret Oethinger United States
John Osei Sekyere South Africa
Carole Ayoub Moubareck United Arab Emirates
Paige Waterman United States
Kang Liao China
Virve I. Enne
Citations per year, relative to Virve I. Enne Virve I. Enne (= 1×) peers Sophie Alexandra Baron

Countries citing papers authored by Virve I. Enne

Since Specialization
Citations

This map shows the geographic impact of Virve I. Enne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virve I. Enne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virve I. Enne more than expected).

Fields of papers citing papers by Virve I. Enne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virve I. Enne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virve I. Enne. The network helps show where Virve I. Enne may publish in the future.

Co-authorship network of co-authors of Virve I. Enne

This figure shows the co-authorship network connecting the top 25 collaborators of Virve I. Enne. A scholar is included among the top collaborators of Virve I. Enne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virve I. Enne. Virve I. Enne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stewart, Sarah-Jane, Zoe Moon, Yogini Jani, et al.. (2023). UK clinicians’ attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study. Journal of Antimicrobial Chemotherapy. 79(1). 123–127. 3 indexed citations
2.
Enne, Virve I., Alp Aydin, Rossella Baldan, et al.. (2022). Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study. Thorax. 77(12). 1220–1228. 50 indexed citations
4.
Horne, Robert, Yogini Jani, Tom W. Reader, et al.. (2021). Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework. BMJ Quality & Safety. 31(3). 199–210. 41 indexed citations
6.
Wagner, Adam P., Virve I. Enne, David M. Livermore, J.V. Craig, & David Turner. (2020). Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia. Journal of Hospital Infection. 106(4). 745–756. 7 indexed citations
7.
Personne, Yoann, et al.. (2017). Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli. Journal of Antimicrobial Chemotherapy. 72(8). 2213–2218. 43 indexed citations
8.
Personne, Yoann, Gareth Platt, Christopher Jeanes, et al.. (2017). The Unyvero P55 ‘sample-in, answer-out’ pneumonia assay: A performance evaluation. SHILAP Revista de lepidopterología. 13. 1–6. 42 indexed citations
9.
Personne, Yoann, et al.. (2016). ‘Sample-in, answer-out’? Evaluation and comprehensive analysis of the Unyvero P50 pneumonia assay. Diagnostic Microbiology and Infectious Disease. 86(1). 5–10. 22 indexed citations
10.
Enne, Virve I., et al.. (2014). Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Current Opinion in Pulmonary Medicine. 20(3). 252–258. 29 indexed citations
11.
Zumla, Alimuddin, Jaffar A. Al‐Tawfiq, Virve I. Enne, et al.. (2014). Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects. The Lancet Infectious Diseases. 14(11). 1123–1135. 128 indexed citations
12.
Thomson, Nicholas R., Christopher M. Thomas, Karen Brooks, et al.. (2012). Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids. BMC Microbiology. 12(1). 53–53. 69 indexed citations
13.
Enne, Virve I. & Peter M. Bennett. (2010). Methods to Determine Antibiotic Resistance Gene Silencing. Methods in molecular biology. 642. 29–44. 10 indexed citations
14.
Liu, Jianjun, et al.. (2009). Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli. Journal of Antimicrobial Chemotherapy. 63(3). 423–426. 37 indexed citations
15.
Enne, Virve I.. (2009). Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?. Journal of Antimicrobial Chemotherapy. 65(2). 179–182. 36 indexed citations
16.
Karami, Nahid, Anna Martner, Virve I. Enne, et al.. (2007). Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. Journal of Antimicrobial Chemotherapy. 60(5). 1142–1145. 93 indexed citations
17.
Enne, Virve I., Anne A. Delsol, J.M. Roe, & Peter M. Bennett. (2006). Evidence of Antibiotic Resistance Gene Silencing in Escherichia coli. Antimicrobial Agents and Chemotherapy. 50(9). 3003–3010. 78 indexed citations
18.
Enne, Virve I.. (2004). Rifampicin resistance and its fitness cost in Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 53(2). 203–207. 60 indexed citations
19.
Livermore, David M., Marina Warner, Lucinda M. C. Hall, et al.. (2001). Antibiotic resistance in bacteria from magpies ( Pica pica ) and rabbits ( Oryctolagus cuniculus ) from west Wales. Environmental Microbiology. 3(10). 658–661. 50 indexed citations
20.
Enne, Virve I., David M. Livermore, Peter Stephens, & Lucinda M. C. Hall. (2001). Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. The Lancet. 357(9265). 1325–1328. 396 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026